Home › Kanser sa Baga › Illinois › Waukegan
Pag-aaral pangklinika para sa Kanser sa Baga sa Waukegan, IL
16 pag-aaral para sa Kanser sa Baga ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Waukegan (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Nagre-recruitPhase 3
- AMG Libertyville - Oncology, Libertyville · 8 mi ang layo
- Condell Memorial Hospital, Libertyville · 8 mi ang layo
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Nagre-recruitPhase 3
- AMG Libertyville - Oncology, Libertyville · 8 mi ang layo
- Condell Memorial Hospital, Libertyville · 8 mi ang layo
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Nagre-recruitPhase 3
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mi ang layo
- Northwestern Medicine Grayslake Outpatient Center, Grayslake · 10 mi ang layo
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- AMG Libertyville - Oncology, Libertyville · 8 mi ang layo
- Condell Memorial Hospital, Libertyville · 8 mi ang layo
Empathic Communication Skills (ECS) Training
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
- Advocate Health Care Network, Libertyville · 8 mi ang layo
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Nagre-recruitPhase 3
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mi ang layo
- Northwestern Medicine Grayslake Outpatient Center, Grayslake · 10 mi ang layo
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Nagre-recruitPhase 3
- Advocate Medical Group - Libertyville Oncology, Libertyville · 8 mi ang layo
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Nagre-recruitPhase 1
- City of Hope - Chicago, Zion · 6 mi ang layo
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Nagre-recruitPhase 3
- City of Hope® Cancer Center Chicago, Zion · 6 mi ang layo
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Nagre-recruitPhase 3
- Midwestern Regional Medical Center, Zion · 6 mi ang layo
- AMG Libertyville - Oncology, Libertyville · 8 mi ang layo
- Condell Memorial Hospital, Libertyville · 8 mi ang layo
Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.
Nagre-recruit
- Captain James A. Lovell Federal Health Care Center, North Chicago · 3 mi ang layo
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Nagre-recruitPhase 2
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mi ang layo
- AMG Libertyville - Oncology, Libertyville · 8 mi ang layo
- Condell Memorial Hospital, Libertyville · 8 mi ang layo
- at 1 pa
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Nagre-recruitPhase 2/3
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mi ang layo
- AMG Libertyville - Oncology, Libertyville · 8 mi ang layo
- Condell Memorial Hospital, Libertyville · 8 mi ang layo
- at 1 pa
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Nagre-recruitPhase 2
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mi ang layo
- Northwestern Medicine Grayslake Outpatient Center, Grayslake · 10 mi ang layo
Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial
Nagre-recruitPhase 2
- City of Hope at Chicago, Zion · 6 mi ang layo
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
Nagre-recruitObservasyonal na pag-aaral
- AMG Libertyville - Oncology, Libertyville · 8 mi ang layo
- Condell Memorial Hospital, Libertyville · 8 mi ang layo
Pag-aaral para sa Kanser sa Baga sa ibang lungsod
- Houston, TX78 pag-aaral
- Boston, MA62 pag-aaral
- New York City, NY60 pag-aaral
- Los Angeles, CA45 pag-aaral
- Arlington, VA41 pag-aaral
- Washington, DC41 pag-aaral
- Chicago, IL41 pag-aaral
- Nashville, TN40 pag-aaral
- Baltimore, MD40 pag-aaral
- St. Louis, MO39 pag-aaral
- Columbus, OH37 pag-aaral
- Philadelphia, PA36 pag-aaral
Iba pang pag-aaral sa Waukegan
- Non-Small Cell Lung Cancer16 pag-aaral
- Kanser sa Suso12 pag-aaral
- Ulcerative Colitis7 pag-aaral
- Kanser sa Bato (Renal Cell Carcinoma)7 pag-aaral
- Kanser sa Ovary6 pag-aaral
- Metastatic Cancer6 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg6 pag-aaral
- Colorectal Cancer6 pag-aaral
- Kanser sa Prostate6 pag-aaral
- Melanoma5 pag-aaral
- Acute Myeloid Leukemia5 pag-aaral
- Crohn's Disease5 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.